Lisdexamfetamine is an effective monotherapy for moderate to severe binge eating disorder

Abstract

A clinical decision report using: McElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M. Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2016;41(5):1251-1260. https://doi.org/10.1038/npp.2015.275 for a young woman requesting a novel pharmacological intervention for a Binge Eating Disorder (BED).